Přejít k hlavnímu obsahu
Header image

Vrbková Jana Ph.D.

Journals

KOUDELÁKOVÁ, V., J. BERKOVCOVÁ, R. TROJANEC, J. VRBKOVÁ, L. RADOVÁ, J. EHRMANN, Z. KOLÁŘ, B. MELICHAR, M. HAJDÚCH
Evaluation of HER2 Gene Status in Breast Cancer Samples with Indeterminate Fluorescence in Situ Hybridization by Quantitative Real-Time PCR Method. Journal of Molecular Diagnostic. 2015, 17(4), 446-455, ISSN: 1525-1578, PMID: 25956448,  PDF.
BOUCHALOVÁ, K., M. SVOBODA, G. KHARAISHVILI, J. VRBKOVÁ, J. BOUCHAL, R. TROJANEC, V. KOUDELÁKOVÁ, L. RADOVÁ, K. CWIERTKA, M. HAJDÚCH, Z. KOLÁŘ
BCL2 is an independent predictor of outcome in basal-like triple-negative breast cancers treated with adjuvant anthracycline-based chemotherapy. Tumor Biology. 2015, 36(6), 4243-52, ISSN: 1010-4283, PMID: 25616695,
SZOTKOWSKI, T., E. FABER, J. HUBACEK, L. RAIDA, P. ROHON, A. KUBA, Z. PIKALOVA, M. HOLZEROVA, M. DIVOKÁ, M. JAROSOVA, J. VRBKOVÁ, T. PAPAJIK, K. INDRAK
Acute promyelocytic leukemia successfully treated also in elderly patients with significant comorbidities: a 20-year single-center experience. Neoplasma. 2015, 62(1), 146-151, ISSN: 0028-2685, PMID: 25563379,